How do immunosuppressive drugs help with allogeneic tissue transplants?

In the context of regenerative medicine, allogeneic tissue transplants involve using cells or tissues from a donor, which introduces foreign antigens that the recipient's immune system typically identifies as "nonself". This recognition triggers an immune response—primarily driven by T lymphocytes—that leads to the destruction of the graft, a process known as rejection.123

Immunosuppressive drugs are essential in these procedures because they inhibit the recipient's immune system, preventing it from attacking and eliminating the foreign tissue. These agents work through various mechanisms:42

• Inhibiting T cells: Many effective drugs, such as calcineurin inhibitors (e.g., cyclosporine and tacrolimus), target the signaling pathways of T lymphocytes, which are responsible for cell-mediated rejection.41
• Suppressing proliferation: Other agents, such as sirolimus and mycophenolate mofetil, inhibit the activation or proliferation of immune cells.4
• Adjunct therapies: Monoclonal and polyclonal antibodies are often used to specifically target proteins on the surface of immune cells to prevent or treat rejection.4

By suppressing these immune responses, these drugs allow the recipient's body to accept the allogeneic graft.45